C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes

Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
12/2002
12/05/2002	US20020183934 Methods for making character strings, polynucleotides and polypeptides having desired characteristics
12/05/2002	US20020183506 Nucleotide sequences coding polypeptide for use in biological pest control
12/05/2002	US20020183505 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/05/2002	US20020183504 Isolated gene of given sequence, from the family of aspartate-specific cysteine proteases (ASCPs); involved in apoptosis
12/05/2002	US20020183494 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/05/2002	US20020183493 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/05/2002	US20020183491 Methods for the isolation of proteinase inhibitor from potato tubers
12/05/2002	US20020183486 Nucleotide sequences coding enzymatic polypeptide for use in the generation of genetically engineered plants seeds; for use in animal feeds
12/05/2002	US20020183276 Administering alkaline phosphatase (TNAP) inhibitor to the tissue or patient effective to inhibit TNAP expression or activity for decreasing matrix mineralization in a tissue
12/05/2002	US20020183269 Novel compounds
12/05/2002	US20020183260 For therapy of cardiovascular disorders in mammals; for inhibiting both angiotensin converting enzyme and neutral endopeptidase in mammals
12/05/2002	US20020183251 For use as vaccines, and other drugs for the diagnosis and therapy of prostate cancer
12/05/2002	US20020183249 Method of identifying inhibitors of CDC25
12/05/2002	US20020183226 Liquid detergent composition exhibiting enhanced alpha-amylase enzyme stability
12/05/2002	US20020182750 Intravascular apparatus method
12/05/2002	US20020182711 Enzymatic unhairing agent for use in tanning for producing leather and method for enzymatic unhairing treatment
12/05/2002	US20020182705 Method for increasing the serum half-life of a biologically active molecule
12/05/2002	US20020182704 Plant proteinases
12/05/2002	US20020182703 Human defensin polypeptide Def-X, genomic DNA and cDNA, composition containing them and applications to diagnosis and to therapeutic treatment
12/05/2002	US20020182702 Nuc,leotide equences coding polypeptide for use in the treatment of cancer and immunological disorders
12/05/2002	US20020182701 Dominant negative variants of methionine aminopeptidase 2 (MetAP2) and clinical uses thereof
12/05/2002	US20020182699 Nucleotide sequences coding enzymatic polypeptide for use in detergents
12/05/2002	US20020182697 Synthetic enzymes for the production of coniferyl alcohol, coniferylaldehyde, ferulic acid, vanillin and vanillic acid and their use
12/05/2002	US20020182696 Stabilized enzyme compositions
12/05/2002	US20020182695 Stabilised enzyme compositions
12/05/2002	US20020182692 Peptide for use in the treatment of cancer, parkinson's and developmental defects
12/05/2002	US20020182689 Nucleotide sequences coding enzymatic polypeptide for use genration of amino acids
12/05/2002	US20020182686 Generating prevential nucleotide sequences; obtain nucleotide sequences, incubate with primers, expose to polymerase, recover nucleotide sequences
12/05/2002	US20020182682 Process for preparing beta-fructofuranosidase enzyme and a process for producing fructooligosaccharides
12/05/2002	US20020182681 Peptide for use in treatment of cancer, parkinson's and metabolic disorders
12/05/2002	US20020182666 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis
12/05/2002	US20020182661 Substrate analogs for MurG, methods of making same and assays using same
12/05/2002	US20020182656 Methods for regulating vascularization using GEF containing NEK-like kinase (GNK)
12/05/2002	US20020182638 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/05/2002	US20020182636 53010, a novel human carboxylesterase family member and uses thereof
12/05/2002	US20020182618 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/05/2002	US20020182582 Process for preparing agents containing virus-inactivated vitamin K-dependent plasma components as well as protein C and protein S by membrane chromatography
12/05/2002	US20020182268 Plant extracts, especially for breast cancer
12/05/2002	US20020182229 Anaerobe targeted enzyme mediated prodrug therapy
12/05/2002	US20020182224 Recombinant fusion protein comprising an amino acid sequence selected from the 27/28 kDa cercarial elastase sequence of S. mansoni fused to a protein selected from suitable bacterial, phage and viral proteins
12/05/2002	US20020182215 Especially the amino acid sequence Ile-Phe-Ala-Gly-Asp-Lys-Phe-Trp-Arg, preferably flanked by cysteine residues at the amino and carboxy termini.
12/05/2002	US20020182205 Administering a therapeutically effective amount of an agonist of the non-proteolytically activated thrombin receptor to the site.
12/05/2002	US20020182203 Stimulate dephosphorylation of DSP-15 substrates; used to identify antibodies and other agents that inhibit DSP-15 activity; modulate cell proliferation, differentiation and survival.
12/05/2002	US20020182201 Matrix stabilized enzyme crystals and methods of use
12/05/2002	CA2616769A1 Compositions and methods of increasing stress tolerance in plants
12/05/2002	CA2449014A1 Method to generate non virulent microorganisms from pathogenic ones trough permanent genetic modification of their biological membrane for vaccine production
12/05/2002	CA2448100A1 Chimeric proteins for cell targeting and apoptosis induction and methods of using the same
12/05/2002	CA2447092A1 Method for the enzymatic production of a curing agent in its fluid state
12/05/2002	CA2445611A1 P-cadherin as a target for anti-cancer therapy
12/05/2002	CA2443821A1 Transgenic plants with reduced adenylate kinase activity showing an increased accumulation of starch
12/05/2002	CA2443713A1 Proteins associated with cell growth, differentiation, and death
12/05/2002	CA2441937A1 Chromosome-based platforms
12/04/2002	EP1262558A1 Method of screening inducible nitric oxide synthase activation inhibitor
12/04/2002	EP1262557A1 Parkin protein as ubiquitin ligase
12/04/2002	EP1262553A1 Luciferase-selection marker fusion proteins, polynucleotides encoding such proteins, and uses thereof
12/04/2002	EP1262552A1 Polynucleotides encoding insect glutaminyl cyclase and uses thereof
12/04/2002	EP1262551A2 A sorbitol dehydrogenase gene, a recombinant DNA, and a process for producing sorbitol dehydrogenase
12/04/2002	EP1262550A2 (R)-2,3-butanediol dehydrogenase, methods for producing same, and methods for producing optically active alcohol using the dehydrogenase
12/04/2002	EP1262541A1 Production of bioavailable folic acid
12/04/2002	EP1262487A1 Dna encoding squalene epoxidase promoter
12/04/2002	EP1262191A1 Pharmaceutical compositions comprising recombinant human acid alpha-glucosidase containing mannose 6-phosphate
12/04/2002	EP1261745A2 Nucleic acids, proteins, and antibodies
12/04/2002	EP1261735A2 Methods and materials relating to leukocyte immunoglobulin receptor-like (lir-like) polypeptides and polynucleotides
12/04/2002	EP1261730A2 A process for generating cytoplasmic male sterile line in rice and other crops by rna editing
12/04/2002	EP1261727A2 Transgenic plants with increased seed yield, biomass and harvest index
12/04/2002	EP1261722A2 18036, a novel calpain-like protease and uses thereof
12/04/2002	EP1261721A1 Human extracellular signal regulated kinases
12/04/2002	EP1261720A2 Cell cycle proteins associated with rad9, compositions and methods of use
12/04/2002	EP1261719A2 27411, a human phosphatidyl-glycerolphosphate (pgp) synthase
12/04/2002	EP1261718A2 Corynebacterium glutamicum genes encoding metabolic pathway proteins
12/04/2002	EP1261708A2 Compositions and methods for the therapy and diagnosis of prostate cancer
12/04/2002	EP1261703A1 Nucleic acids, proteins, and antibodies
12/04/2002	EP1261699A1 Protecting molecules in biologically derived compositions while treating with broad-spectrum pulsed light
12/04/2002	EP1261698A1 Family 5 xyloglucanases
12/04/2002	EP1261697A1 Cold-active beta galactosidase, the process for its preparation and the use thereof
12/04/2002	EP1261696A1 Rna polymerase mutants with increased thermostability
12/04/2002	EP1261695A2 Methods for making plants tolerant to glyphosate and compositions thereof
12/04/2002	EP1261639A2 Chondromodulin-i related peptide
12/04/2002	EP1261637A1 Nucleic acids, proteins, and antibodies
12/04/2002	EP1261636A2 Human protein kinases and protein kinase-like enzymes
12/04/2002	EP1261635A1 Human polynucleotides, polypeptides, and antibodies
12/04/2002	EP1261634A1 Nucleic acids, proteins, and antibodies
12/04/2002	EP1261633A2 Nucleic acids, proteins, and antibodies
12/04/2002	EP1261618A2 Nucleic acids, proteins, and antibodies
12/04/2002	EP1261583A1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES
12/04/2002	EP1261380A1 Nucleic acids, proteins and antibodies
12/04/2002	EP1261379A2 Genetic modification of the lung as a portal for gene delivery
12/04/2002	EP1261368A2 Lipase-containing composition and methods of use thereof
12/04/2002	EP1261252A2 Sulfonylurea-tolerant sunflower plants
12/04/2002	EP0929636B1 Liquid detergents containing proteolytic enzyme, peptide aldehyde and a source of boric acid
12/04/2002	EP0781328B1 Enhancers such as acetosyringone
12/04/2002	EP0701623B2 Process for the preparation of n-acetylneuraminic acid
12/04/2002	EP0638092B1 Synthetic peptide vaccines for dental caries
12/04/2002	EP0517817B1 Inhibitors of catalytic antibodies
12/04/2002	CN1382804A Refractor phosphoribose anthranilic acid isomerase gene and its polypeptide coded by it and preparing process
12/04/2002	CN1382802A Process for preparing biologic silica gel containing dehydrogenase
12/04/2002	CN1382801A Polypeptide-DNA topoisomerase 1-9.13 and polynucleotide for coding it
12/04/2002	CN1382800A Polypeptide-chitotriase-52.03 and polynucleotide for coding it
12/04/2002	CN1382799A Polypeptide-human carboxylatase-24.64 and polynucleotide for coding it
12/04/2002	CN1382798A Polypeptide-diphosphoadenosine ribodiphosphatase-38.5 and pharmaceutical compound containing it

1 ... 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 ... 1416